Steady-State Pharmacokinetic Comparison Study of TNX-102 SL 5.6 mg Versus AMRIX® 30 mg ER Capsules
Clinical trial NCT03443960 · COMPLETED
Trial details
- NCT number
- NCT03443960
- Sponsor
- Tonix Pharmaceuticals, Inc.
- Status
- COMPLETED
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2018-01-29
- Primary completion
- 2018-04-09
- Enrollment
- 60
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.